Viewing nowTrucita Tablets 25 mg (Sitagliptin hydrochloride monohydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

MFDS item code 202101847 · Approved 2021.02.24 · Insurance code 641908130
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. Initially, it may be administered alone in conjunction with diet and exercise therapy. However, if blood sugar control is difficult with monotherapy, it is used in combination with metformin. Additionally, this medication can be added when blood sugar control is insufficient with other diabetes medications such as sulfonylureas, thiazolidinediones, or insulin. It is effective in improving the management of patients' blood sugar with various methods of blood sugar control in combination.
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medication and periodically during treatment. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.
This medication may cause severe allergic reactions, so if symptoms such as skin rash or swelling occur, discontinue use immediately and consult a doctor. During the use of this medication, symptoms of pancreatitis, an inflammation of the pancreas, may appear; if abdominal pain or vomiting worsens, inform healthcare professionals immediately. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor should it be taken if there is an allergy to this medication or its components. Patients with reduced kidney function need to adjust the dosage of this medication, so appropriate dosing should be determined through renal function tests. Patients in clinical trials taking this medication experienced symptoms such as nasopharyngitis, upper respiratory infections, headaches, and diarrhea compared to a placebo, with an increased risk of hypoglycemia especially when taken with insulin or sulfonylureas. During the use of this medication, severe joint pain or the development of blisters on the skin may occur; if these symptoms appear, notify a doctor immediately. There is a risk of hypoglycemia when taking this medication with other hypoglycemic agents, so it may be necessary to adjust the doses of insulin or sulfonylureas. Pregnant or breastfeeding women should avoid using this medication, and safety in pediatric patients under 18 years of age has not been established. Older adults may have decreased kidney function, so it is important to periodically monitor renal function before and during use. In cases of overdose, some drugs may be removed through hemodialysis, and general emergency treatment should be provided. No major interactions have been reported when this medication is taken with other medications; however, monitoring of blood concentration is necessary when taken with digoxin. If abnormal symptoms appear during the use of this medication, it is important to consult healthcare professionals immediately to receive appropriate action.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture from entering. The appropriate storage temperature is room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
Pink round biconvex film-coated tablets
PTP - 28 tablets per box [(14 tablets/PTP × 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.